ANTARA

Serial Number 78433786
Registration 3101801
800

Registration Progress

Application Filed
Jun 11, 2004
Under Examination
Jan 17, 2006
Approved for Publication
Oct 5, 2005
Published for Opposition
Oct 25, 2005
Registered
Jun 6, 2006

Attorney Assistance

Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-06-06)
Due: Jun 06, 2026 332 days

Basic Information

Serial Number
78433786
Registration Number
3101801
Deadline
June 6, 2026
Description
10 Year - Section 8 and 9 Renewal
Filing Date
June 11, 2004
Registration Date
June 6, 2006
Published for Opposition
October 25, 2005
Renewal Date
June 6, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Jul 24, 2016
Registration
Registered
Classes
005

Rights Holder

LUPIN INC.

03
Address
111 SOUTH CALVERT STREET
BALTIMORE, MD 21202

Ownership History

Reliant Pharmaceuticals, Inc.

Original Applicant
03
Liberty Corner, NJ

Reliant Pharmaceuticals, Inc.

Owner at Publication
03
Liberty Corner, NJ

Reliant Pharmaceuticals, Inc.

Original Registrant
03
Liberty Corner, NJ

LUPIN ATLANTIS HOLDINGS, S.A.

New Owner After Registration #1
03
SCHAFFHAUSEN CH

LUPIN INC.

New Owner After Registration #2
03
BALTIMORE, MD

Legal Representation

Attorney
Paul J. Kennedy

USPTO Deadlines

Next Deadline
332 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-06-06)
Due Date
June 06, 2026
Grace Period Ends
December 06, 2026

Application History

43 events
Date Code Type Description
Jun 6, 2025 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 28, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 24, 2016 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 24, 2016 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 24, 2016 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 24, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 5, 2016 E89R I TEAS SECTION 8 & 9 RECEIVED
Jun 6, 2015 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 4, 2013 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 4, 2013 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 4, 2013 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 5, 2012 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 5, 2012 E815 I TEAS SECTION 8 & 15 RECEIVED
Jul 28, 2010 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 3, 2008 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 5, 2007 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 14, 2007 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 10, 2007 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 26, 2006 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 26, 2006 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 18, 2006 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 27, 2006 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 6, 2006 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 26, 2006 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
Apr 14, 2006 ALIE A ASSIGNED TO LIE
Apr 10, 2006 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 31, 2006 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 15, 2006 IUAF S USE AMENDMENT FILED
Mar 15, 2006 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 17, 2006 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 25, 2005 PUBO A PUBLISHED FOR OPPOSITION
Oct 5, 2005 NPUB O NOTICE OF PUBLICATION
Aug 3, 2005 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 29, 2005 ALIE A ASSIGNED TO LIE
Jul 22, 2005 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2005 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2005 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2005 MAIL I PAPER RECEIVED
Jan 12, 2005 GNRT F NON-FINAL ACTION E-MAILED
Jan 12, 2005 CNRT R NON-FINAL ACTION WRITTEN
Jan 12, 2005 DOCK D ASSIGNED TO EXAMINER
Jun 17, 2004 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS
First Use Anywhere: Feb 1, 2005
First Use in Commerce: Feb 1, 2005

Classification

International Classes
005